
Dalton Transactions p. 4437 - 4450 (2014)
Update date:2022-08-04
Topics:
Hohloch, Stephan
Schweinfurth, David
Sommer, Michael G.
Weisser, Fritz
Deibel, Naina
Ehret, Fabian
Sarkar, Biprajit
The compounds [Ru(bpy)2(L1)](ClO4) 2 (1(ClO4)2), [Ru(bpy)2(L 2)](ClO4)2 (2(ClO4)2), [Ru(bpy)2(L3)](ClO4)2 (3(ClO 4)2), [Ru(bpy)2(L4)](ClO 4)2 (4(ClO4)2), [Ru(bpy) 2(L5)](ClO4)2 (5(ClO 4)2), and [Ru(bpy)2(L6)](ClO 4)26(ClO4)2 (bpy = 2,2′-bipyridine, L1 = 1-(4-isopropyl-phenyl)-4-(2-pyridyl)-1,2, 3-triazole, L2 = 1-(4-butoxy-phenyl)-4-(2-pyridyl)-1,2,3-triazole, L3 = 1-(2-trifluoromethyl-phenyl)-4-(2-pyridyl)-1,2,3-triazole, L4 = 4,4′-bis-{1-(2,6-diisopropyl-phenyl)}-1,2,3-triazole, L5 = 4,4′-bis-{(1-phenyl)}-1,2,3-triazole, L6 = 4,4′-bis-{1-(2-trifluoromethyl-phenyl)}-1,2,3-triazole) were synthesized from [Ru(bpy)2(EtOH)2](ClO4)2 and the corresponding click -derived pyridyl-triazole or bis-triazole ligands, and characterized by 1H-NMR spectroscopy, elemental analysis, mass spectrometry and X-ray crystallography. Structural analysis showed a distorted octahedral coordination environment about the Ru(ii) centers, and shorter Ru-N(triazole) bond distances compared to Ru-N(pyridine) distances in complexes of mixed-donor ligands. All the complexes were subjected to cyclic voltammetric studies, and the results were compared to the well-known [Ru(bpy)3]2+ compound. The oxidation and reduction potentials were found to be largely uninfluenced by ligand changes, with all the investigated complexes showing their oxidation and reduction steps at rather similar potentials. A combined UV-vis-NIR and EPR spectroelectrochemical investigation, together with DFT calculations, was used to determine the site of electron transfer in these complexes. These results provided insights into their electronic structures in the various investigated redox states, showed subtle differences in the spectroscopic signatures of these complexes despite their similar electrochemical properties, and provided clues to the unperturbed redox potentials in these complexes with respect to ligand substitutions. The reduced forms of the complexes display structured absorption bands in the NIR region. Additionally, we also present new synthetic routes for the ligands presented here using Cu-abnormal carbene catalysts.
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Contact:+36(21)2523420
Address:Head office: 1102 Budapest, SZENT LASZLO TER 24/B. 1/1., HUNGARY / CHINA
shanghai Tauto Biotech Co., Ltd
website:http://www.tautobiotech.com/en/index.htm
Contact:+86-21-51320588 ext. 8025
Address:No. 326, Aidisheng Rd , Zhangjiang Hi-tech Park, Shanghai , P.R.CHINA
HANGZHOU EVC CHEMICAL CO.,LTD.(expird)
Contact:+86-571-88296056
Address:Room#3001,Zhejiang Chemical Market,No.10,Road Shenban,Hangzhou,Zhejiang,China
zhangjiagang bonded areas banggao co;ltd
website:http://www.shunchangchem.com
Contact:0086-13921972933
Address:Dongsha Chemical Zone.Zhangjiagang, Jiangsu Province
Doi:10.1039/C6DT04811K
(2017)Doi:10.1016/j.tetasy.2008.03.016
(2008)Doi:10.1021/ja00279a059
(1986)Doi:10.1016/j.tet.2008.03.038
(2008)Doi:10.1016/S0040-4039(00)95141-4
(1985)Doi:10.1016/S0040-4020(01)96713-4
(1985)